Abstract
238 human immunodeficiency virus-infected patients on highly active antiretroviral therapy (HAART) were studied, 67 of whom (28.2%) developed lipodystrophy. The presence of hyperlipidaemia (p=0.002) and of hepatitis C virus coinfection (p=0.014) were associated with lipodystrophy, but only the duration of HAART was significantly predictive of lipodystrophy (p<0.0001) in the multivariate analysis.